Charles Bennett to Quinazolines
This is a "connection" page, showing publications Charles Bennett has written about Quinazolines.
Connection Strength
0.341
-
Cost-effectiveness considerations in the treatment of essential thrombocythemia. Semin Oncol. 2002 Jun; 29(3 Suppl 10):28-32.
Score: 0.191
-
Cost-effectiveness model of a phase II clinical trial of a new pharmaceutical for essential thrombocythemia: is it helpful to policy makers? Semin Hematol. 1999 Jan; 36(1 Suppl 2):26-9.
Score: 0.151